-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$276.5972.05% Upside
Recent Analyst Forecasts and Stock Ratings
Biogen Inc. Frequently Asked Questions
-
What analysts cover Biogen Inc.?
Biogen Inc. has been rated by research analysts at Robert W. Baird, Oppenheimer, Morgan Stanley, Raymond James, Goldman Sachs, BMO Capital in the past 90 days.